Missouri Patent of the Month – October 2022

Founded in 2005, Veran Medical Technologies, Inc. has focused their expertise on empowering earlier cancer diagnoses. Their approach to this mission is through the development of tools that better support doctors. Their main, proprietary system is their SPiN Thoracic Navigation System® which puts you in control of bronchoscopic yields to help speed time to diagnosis. 

There has been an increase in the number of patients expecting lung cancer screening, definitive diagnostics can help prevent unneeded lung resurrections. Only about 4% of patients from the initial screening are found to have a malignancy. Veran Medical’s SPiN system, supported by their newly patented localization needle, helps to more accurately and efficiently detect target malignant tissues from less than 2 cm in size. Peripheral target tissues smaller than 2 cm have been historically difficult to detect.

The localized needle can intercept target tissues within the airway as well as sub-surface tissues beyond the wall of the airway. By displaying the preferred entry site and trajectory view of the percutaneous needle, the physician is granted access to easy-to-understand localization information.

The needle is designed with patient tracking devices which each have a marker and a localization element. The markers are visible in the imaging captured by the SPiN system while the position and orientation (POSE) of localization elements are tracked by the localization device in the imaging system. In addition to these tracking components, the needle has a hollow cannula that allows for a switch between bronchoscopy and percutaneous approaches. This range of offerings provides precision guidance for marker and dye placement, allowing for improved diagnostic accuracy with reduced irritation to the lungs and airway.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts